Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
11/2013
11/13/2013CN102553583B Mesoporous carbon-loaded gold nano catalyst and application thereof
11/13/2013CN102229538B Method for synthesizing dapoxetine
11/07/2013US20130296577 Novel photoinitiators
11/07/2013US20130296537 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
11/07/2013US20130296414 1-Phenyl-2-Dimethylaminomethyl Cyclohexane Compounds And Therapies For Depressive Symptoms, Pain and Incontinence
11/07/2013US20130296346 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
11/06/2013CN103382159A Venlafaxine hydrochloride preparation method
11/06/2013CN102382294B Preparation method for series products of polyether amine
10/2013
10/31/2013US20130289118 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
10/31/2013US20130289076 Cyclopropylamine inhibitors of oxidases
10/30/2013CN103374114A Benzylamine hdrophobe
10/30/2013CN103373932A Method for synthesizing alkylamine polyethenoxy ether
10/30/2013CN103373931A Industrial preparation method of apoxetine and intermediate of apoxetine
10/30/2013CN103373929A Dibenzylamine hydrophobe
10/30/2013CN102153483B Axial chirality vicinal diamine compound and preparation method thereof
10/30/2013CN102030668B Preparation method of dimethylamine butyral
10/30/2013CN101774932B Method for producing substituted dimethyl-(3-aryl-butyl)-amine compounds
10/30/2013CN101768149B Beta- aminoketone (alkamine) derivatives and use thereof
10/30/2013CN101495445B Process for preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
10/29/2013US8569371 Crystal forms of O-desmethylvenlafaxine fumarate
10/29/2013CA2690229C Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
10/29/2013CA2627648C Photo-responsive microencapsulation materials, compositions and methods of use thereof
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281617 Benzylamine hydrophobe
10/24/2013US20130280305 Cationic lipid
10/23/2013EP2653464A1 Benzylamine hydrophobe
10/23/2013EP2653463A1 Dibenzylamine hydrophobe
10/23/2013CN103370302A Process for the direct amination of alcohols using ammonia to form primary amines by means of a Xantphos catalyst system
10/23/2013CN103361081A Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display component, polymer and compound
10/23/2013CN103360270A Serine derived chiral amine compound as well as preparation method and application thereof
10/23/2013CN102503843B Preparation method for metoprolol salt
10/23/2013CN102146007B Method for preparing secondary amine and tertiary amine
10/20/2013CA2810958A1 Dibenzylamine hydrophobe
10/20/2013CA2810955A1 Benzylamine hydrophobe
10/17/2013US20130274523 Low molecular weight cationic lipids for oligonucleotide delivery
10/16/2013EP2649040A1 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
10/16/2013EP2648707A1 Hydroxylated tricyclic compounds
10/16/2013CN103351305A 4-(2-dimethylaminoethoxy)benzylamine preparation method
10/16/2013CN103351304A Synthesis method of clomiphene
10/16/2013CN102391136B Method and device for producing 4,4-diaminodiphenyl ethers by using catalytic hydrogenation process
10/16/2013CN102311352B Synthesis method for 2-methoxy-4-methylbenzylamine
10/09/2013EP2646489A1 Blowing catalyst
10/09/2013EP2646410A1 Novel agents for reworkable epoxy resins
10/09/2013EP2646408A1 Process for the preparation of 2-methoxymethyl-1,4-benzenediamine, its derivatives thereof and the salts thereof
10/09/2013CN103347509A Compound and composition for treatment of cancer
10/09/2013CN103342651A Synthesis method of diaryl aniline compound
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/03/2013WO2013148125A1 Quaternary ammonium hydroxides
10/03/2013US20130261298 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/03/2013US20130261178 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
10/03/2013US20130261039 Quaternary ammonium hydroxides
10/02/2013EP2643332A2 Method for buffering a chemical or biological composition
10/02/2013EP2643290A1 Calcium-sensing receptor-active compounds
10/02/2013EP2642987A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
10/02/2013CN103339101A Novel precursor
10/02/2013CN103339100A Isotopic carbon choline analogs
10/02/2013CN103333076A New synthesis method of substituted 2-hydroxyethylamine compound
10/01/2013US8546616 Polyetheramine macromonomers comprising two neighboring hydroxyl groups and their use for producing polyurethanes
10/01/2013US8546615 Solid dapoxetine
10/01/2013CA2633374C Amine compound and use thereof for medical purposes
09/2013
09/26/2013US20130253064 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
09/26/2013US20130252964 Compounds And Methods For Treating Candidiasis And Aspergillus Infections
09/25/2013EP2641897A2 A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
09/25/2013EP2641893A1 Process for the preparation of salmeterol and its salts
09/25/2013CN103328433A Analgesic compounds, methods, and formulations
09/25/2013CN103319689A Emulsion resin for high-throwing-power cathode electrophoretic paint and preparation method thereof
09/25/2013CN103319373A Preparation method and related intermediates of 1-[2-amino-1-(4-benzyloxyphenyl)-ethyl]-cyclohexanol
09/25/2013CN102229537B Method for synthesizing citric acid diphenhydramine
09/25/2013CN101868461B Process for the synthesis of E1 activating enzyme inhibitors
09/24/2013US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention
09/19/2013WO2013138443A1 Amine treating process for acid gas separation using blends of amines and alkyloxyamines
09/19/2013WO2013135237A1 Aromatic amine-terphenyl compounds and use thereof in organic semiconducting components
09/19/2013WO2013046194A3 The novel reference markers for fesoterodine fumarate
09/19/2013US20130245321 Sphingosine kinase type 1 inhibitors
09/18/2013EP2638088A1 Halogenation of 4,4'-methylene-bis-anilines
09/18/2013CN103313707A Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
09/18/2013CN103304434A Novel synthesizing method of dapoxetine
09/18/2013CN102343264B Preparation method of 2,5-dimethoxy-4-chloronitrobenzene hydrogenation catalyst
09/18/2013CN102206293B Photoinitiator, UV curing coating and in mo1d decoration method
09/12/2013WO2013132006A1 Method for synthesising aminobiphenyls using aryl hydrazines
09/11/2013EP2636666A1 Trans-2-decenoic acid derivative and medicament containing same
09/11/2013CN103298777A Phenylketone carboxylate compounds and pharmaceutical uses thereof
09/11/2013CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases
09/11/2013CN103288722A High-selectivity synthesis method of secondary amine
09/11/2013CN103288665A Preparation method of capsaicine
09/11/2013CN103288660A N-methylation method of aromatic amine
09/11/2013CN102531912B Preparation method of N-alkyl arylamine
09/10/2013US8529796 Charge transport compositions and electronic devices made with such compositions
09/10/2013CA2511683C An efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
09/06/2013WO2013054273A3 Process for the preparation of agomelatine
09/06/2013WO2013037705A9 Aniline derivatives,their preparation and their therapeutic application
09/05/2013US20130230542 ROS-Activated Compounds as Selective Anti-Cancer Therapeutics
09/04/2013EP2632885A1 Phenylketone carboxylate compounds and pharmaceutical uses thereof
09/04/2013EP2632452A1 Compounds and compositions for the treatment of cancer
09/04/2013CN103282343A Choline analogue as radiotracer
09/04/2013CN103274953A Naphthol and o-naphthoquinone compounds thereof and preparation method and medical application thereof
09/04/2013CN101302169B Orientation material of liquid crystal display elements and manufacture method thereof
08/2013
08/29/2013WO2013126803A1 Trialkyl cationic lipids and methods of use thereof
08/29/2013US20130225687 Compounds and methods for pkc theta inhibition
08/29/2013US20130225679 Analgesic compounds, methods, and formulations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 140